Mutant p53 elicits context-dependent pro-tumorigenic phenotypes | Oncogene
Mutations of the p53 Gene as a Prognostic Factor in Aggressive B-Cell Lymphoma | NEJM
Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma
The p53 network: cellular and systemic DNA damage responses in cancer and aging: Trends in Genetics
The function of a heterozygous p53 mutation in a Li-Fraumeni syndrome patient | PLOS ONE
Omics analyses of a somatic Trp53R245W/+ breast cancer model identify cooperating driver events activating PI3K/AKT/mTOR signaling | PNAS
Scientists unveil chemotherapy resistance mechanism related to p53 mutation
Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma
IJMS | Free Full-Text | Do Mutations Turn p53 into an Oncogene?
Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway
The p53 Protein: Mutations, Cancer & Cell Signalling - Assay Genie
![Significance of TP53 mutation in bladder cancer disease progression and drug selection [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2019/8261/1/fig-1-full.png "Significance of TP53 mutation in bladder cancer disease progression and drug selection [PeerJ]")
Significance of TP53 mutation in bladder cancer disease progression and drug selection [PeerJ]
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden | Genome Medicine | Full Text
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis | Nature Communications
Recurrent somatic mutations reveal new insights into consequences of mutagenic processes in cancer | PLOS Computational Biology
Frontiers | A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer
Gaining insights into relevance across cancers based on mutation features of TP53 gene - ScienceDirect
An unexpected role for p53 in regulating cancer cell–intrinsic PD-1 by acetylation | Science Advances
Targeting Cavity-Creating p53 Cancer Mutations with Small-Molecule Stabilizers: the Y220X Paradigm | ACS Chemical Biology
p53 Is the Most Frequently Mutated Gene in Cancer, but Can We Target It?
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine
TP53 mutation spectrum in primary colorectal cancers. a Proportion of... | Download Scientific Diagram
LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma
